Abbott To Pull Meridia In US Over Heart Risks

Law360, New York (October 8, 2010, 2:35 PM EDT) -- Federal regulators announced Friday that Abbott Laboratories had agreed to take diet drug Meridia off the market because of results from a clinical study showing it increases the risk of heart attack or stroke.

The U.S. Food and Drug Administration asked Abbott to withdraw the obesity drug after reviewing data from a post-marketing study that found Meridia increased by 16 percent the risk of serious heart events, which also included the need for resuscitation after heart stoppage.

Abbott pointed out Friday that the majority of the...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.